Understanding the delay in starting antiretroviral therapy despite recent guidelines for HIV patients retained in care

References

• Abdool Karim, S. S., Naidoo, K., Grobler, A., Padayachi, N., Baxter, C., Gray, A. L., … Abdool Karim, Q. (2011). Integration of antiretroviral therapy with tuberculosis treatment. New England Journal of Medicine, 365(16), 1492–1501. doi: 10.1056/NEJMoa1014181
   PubMed Web of Science ®Google Scholar
• Adedinsewo, D. A., Wei, S. C., Robertson, M., Rose, C., Johnson, C. H., Dombrowski, J., & Skarbinski, J. (2014). Timing of antiretroviral therapy initiation in a nationally representative sample of HIV-infected adults receiving medical care in the United States. AIDS Patient Care and STDs, 28(12), 613–621. doi: 10.1089/apc.2014.0194
   PubMed Web of Science ®Google Scholar
• Althoff, K. H., Rebeiro, P., Brooks, J. T., Buchacz, K., Gebo, K., Martin, J., … Mendes A. (2014). Disparities in the quality of HIV care when using US Department of Health and Human Services indicators. Clinical Infectious Diseases, 58(8), 1185–1189. doi: 10.1093/cid/ciu044
   PubMed Web of Science ®Google Scholar
• Beer, L., Valverde, E., Raiford, J., Weiser, J., White, B., & Skarbinski, J. (2015). Clinician perspectives on delaying initiation of antiretroviral therapy for clinically eligible HIV-infected patients. Journal of the International Association of Providers of AIDS Care, 14(3), 245–254.
   Google Scholar
• British HIV Association. (2012). British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy. HIV Medicine, 15(S1), 1–6.
   Google Scholar
• Centers for Disease Control and Prevention. (2014). Recommendations for HIV prevention with adults and adolescents with HIV in the United States. Atlanta, GA: Author.
   Google Scholar
• Chrisopoulos, K., Olender, S., Lopez, A., Lekas, H., Jaiswal, J., Mellman, W., … Koester, K. (2015). Retained in HIV care but not on antiretroviral treatment: A qualitative patient-provider dyadic study. PLoS Medicine, 12(8), e1001863. doi: 10.1371/journal.pmed.1001863
   Google Scholar
• Edwards, J., Cole, S., Westreich, D., Mugavero, M., Eron, J., Moore, R., … Williams, C. (2015). Age at entry into care, timing of antiretroviral therapy initiation, and 10-year mortality among HIV-seropositive adults in the United States. Clinical Infectious Diseases, 61(7), 1189–1195. doi: 10.1093/cid/civ463
   PubMed Web of Science ®Google Scholar
• Gagliardo, C., Murray, M., Saiman, L., & Neu, N. (2013). Initiation of antiretroviral therapy in youth with HIV: A U.S.-based provider survey. AIDS Patient Care and STDs, 27(9), 498–502. doi: 10.1089/apc.2013.0110
   PubMed Web of Science ®Google Scholar
• Gardner, E. M., McLees, M. P., Steiner, J. F., del Rio, C., & Burman, W. J. (2011). The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clinical Infectious Diseases, 52(6), 793–800. doi: 10.1093/cid/ciq243
   PubMed Web of Science ®Google Scholar
• Gunthard, H., Aberg, J., Eron, J., Hoy, J., Telenti, A., Benson, C., … Volberding, P. (2014). Antiretroviral treatment of adult HIV infection: 2014 Recommendations of the International Antiviral Society – USA Panel. Journal of the American Medical Association, 312(4), 410–425. doi: 10.1001/jama.2014.8722
   PubMed Web of Science ®Google Scholar
• Guthrie, B. L., Choi, R. Y., Mackelprang, R. Y., Rositch, A. F., Bosire, R., Manyara, L., … Farquhar, C. (2011). Barriers to antiretroviral initiation in HIV-1-discordant couples. Journal of Acquired Immune Deficiency Syndromes, 58, e87–e93. doi: 10.1097/QAI.0b013e31822f064e
   Google Scholar
• Hall, H. I., Frazier, E. L., Rhodes, P., Holtgrave, D. R., Furlow-Parmley, C., Tang, T., … Skarbinski, J. (2013). Differences in human immunodeficiency virus care and treatment among subpopulations in the United States. JAMA Internal Medicine, 173(14), 1337–1344. doi: 10.1001/jamainternmed.2013.6841
   PubMed Web of Science ®Google Scholar
• Hanna, D., Buchacz, K., Gebo, K., Hessol, N., Horberg, M., Jacobson, L., … Gange, S. (2013). Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001–2009. Clinical Infectious Diseases, 56, 1174–1182. doi: 10.1093/cid/cit003
   PubMed Web of Science ®Google Scholar
• The INSIGHT START Study Group. (2015). Initiation of antiretroviral therapy in early asymptomatic HIV infection. New England Journal of Medicine, 373(9), 795–807. doi: 10.1056/NEJMoa1506816
   PubMed Web of Science ®Google Scholar
• Kitahata, M. M., Gange, S. J., Abraham, A. G., Merriman, B., Saag, M. S., Justice, A. C., … Moore, R. D. (2009). Effect of early versus deferred antiretroviral therapy for HIV on survival. New England Journal of Medicine, 360(18), 1815–1826. doi: 10.1056/NEJMoa0807252
   PubMed Web of Science ®Google Scholar
• Kurth, A., Beauchamp, M., McKinstry, L., Farrior, J., Buchacz, K., Donnell, D., … El-Sadr, W. (2012). Clinician practices and attitudes regarding early antiretroviral therapy in the United States. Journal of Acquired Immune Deficiency Syndromes, 61(5), e65–e69. doi: 10.1097/QAI.0b013e31826a184c.
   PubMed Web of Science ®Google Scholar
• Leaver, C. A., Bargh, G., Dunn, J. R., & Hwang, S. W. (2007). The effects of housing status on health-related outcomes in people living with HIV: A systematic review of the literature. AIDS and Behavior, 11, 85–100. doi: 10.1007/s10461-007-9246-3
   PubMed Web of Science ®Google Scholar
• Manzardo, C., Esteve, A., Ortega, N., Podzamczer, D., Murillas, J., Segura, F., … Miró, J. M. (2013). Optimal timing for initiation of highly active antiretroviral therapy in treatment-naïve human immunodeficiency virus-1-infected individuals presenting with AIDS-defining diseases: The experience of the PISCIS Cohort. Clinical Microbiology and Infection, 19(7), 646–653. doi: 10.1111/j.1469-0691.2012.03991.x
   PubMed Web of Science ®Google Scholar
• McGrath, N., Glynn, J. R., Saul, J., Kranzer, K., Jahn, A., Mwaungulu, F., … Crampin, A. C. (2010). What happens to ART-eligible patients who do not start ART? Dropout between screening and ART initiation: A cohort study in Karonga, Malawi. BMC Public Health, 10, 601. doi:10.1186/1471-2458-10-601.
   PubMed Web of Science ®Google Scholar
• Nosyk, B., Montaner, J. S. G., Colley, G., Lima, V. D., Chan, K., Heath, K., … Hogg, R. S. (2014). The cascade of HIV care in British Columbia, Canada, 1996–2011: A population-based retrospective cohort study. The Lancet Infectious Diseases, 14(1), 40–49. doi: 10.1016/S1473-3099(13)70254-8
   PubMed Web of Science ®Google Scholar
• Palepu, A., Milloy, M., Kerr, T., Zhang, R., & Wood, E. (2011). Homelessness and adherence to antiretroviral therapy among a cohort of HIV-infected injection drug users. Journal of Urban Health, 88(3), 545–555. doi: 10.1007/s11524-011-9562-9
   PubMed Web of Science ®Google Scholar
• Westergaard, R. P., Ambrose, B. K., Mehta, S. H., & Kirk, G. D. (2012). Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: A survey of North American HIV providers. Journal of the International AIDS Society, 15(1), 10–10. doi: 10.1186/1758-2652-15-10
   PubMed Web of Science ®Google Scholar
• When to Start Consortium. (2009). Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: A collaborative analysis of 18 HIV cohort studies. The Lancet, 373, 1352–1363. doi: 10.1016/S0140-6736(09)60612-7
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2015). Guidelines on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva: Author.
   Google Scholar